Lakewood-Amedex names USC professor to chair diabetic foot ulcer trial
Tweet Send to a Friend
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) has appointed David G. Armstrong, DPM, M.D., Ph.D., as Study Chair for its Phase 2a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
